The Tri-Institutional MD-PhD Program is comprised of Weill Cornell Medicine, The Rockefeller University, and Memorial Sloan Kettering Cancer Center. Each institution brings a diverse perspective and student body to the Program.
Established in 1898, Cornell University Medical College has evolved and grown over the years into the institution known as Weill Cornell Medicine (WCM) today. WCM’s mission--Care, Discover, Teach--contributes to values of the Tri-Institutional MD-PhD Program. With Cornell University a few hours away and Cornell Tech just across the East River, WCM is in a unique position to bring its innovative research and discoveries to New York City. WCM is also known for its diverse faculty, commitment to exceptional patient care, and leading education of future physicians.
The Rockefeller University’s goal is to bring together the best scientists to solve global public health problems. In 1906, Rockefeller became the first biomedical research institute in the United States and has become a hub that links laboratory findings to the bedside. Rockefeller brings excellence in research and education to the Tri-Institutional MD-PhD Program.
Memorial Sloan Kettering Cancer Center (MSK) is known for its specialization in cancer and dedication to patient care. MSK educational programs prepare physicians and scientists to offer innovative cancer treatments to patients around the world. The collaboration with the Tri-Institutional MD-PhD Program is a way for MSK to develop a cadre of cancer experts within New York City.